US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Neumora Therapeutics, Inc.

1.33

0.0000

Post-market: 1.32-0.0100-0.75%17:51 EDT

Volume:532.62K

Turnover:709.96K

Market Cap:250.04M

PE:-1.09

High:1.36

Open:1.33

Low:1.31

Close:1.33

52wk High:3.65

52wk Low:0.8302

Shares:188.00M

Float Shares:116.00M

Volume Ratio:0.93

T/O Rate:0.46%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.2237

EPS(LYR):-1.4501

ROE:-187.11%

ROA:-73.85%

PB:5.62

PE(LYR):-0.92

Loading ...

Overview Company News Filings

Neumora Therapeutics Price Target Maintained With a $8.00/Share by Needham

Neumora Therapeutics Warns Nasdaq Delisting Risk Could Hit Liquidity, Share Price, and Capital Access

Analysts Conflicted on These Healthcare Names: Connect Biopharma Holdings (CNTB), Neumora Therapeutics, Inc. (NMRA) and Merck & Company (MRK)

Neumora Therapeutics Inc reports results for the quarter ended December 31 - Earnings Summary

Neumora Therapeutics Q4 EPS $(0.35) Misses $(0.33) Estimate

Benzinga Earnings

Neumora Therapeutics reports Q4 EPS (35c), consensus (33c)

Neumora FY25 net loss narrows to $237 million; cash drops to $183 million

Neumora Therapeutics Inc: NOW Expects to Bring Nmra-215 Into Clinic in Q1 of 2027

THOMSON REUTERS

Press Release: Neumora Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

Neumora publishes corporate presentation outlining neuroscience pipeline and upcoming clinical milestones

Calendar of U.S. Earnings Expected in the Week Ahead

Neumora Therapeutics Inc expected to post a loss of 33 cents a share - Earnings Preview

Calendar of U.S. Earnings Expected in the Week Ahead

Neumora Therapeutics to report Q4 and full-year 2025 financial results in conference call and webcast

LB Pharmaceuticals appoints Robert Lenz to board

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigerplaytime.com/stock/NMRA/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NMRA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NMRA\",,,,,undefined,":{"symbol":"NMRA","market":"US","secType":"STK","nameCN":"Neumora Therapeutics, Inc.","latestPrice":1.33,"timestamp":1788292800000,"preClose":1.33,"halted":0,"volume":532615,"hourTrading":{"tag":"盘后","latestPrice":1.32,"preClose":1.33,"latestTime":"17:51 EDT","volume":1585,"amount":2107.050182,"timestamp":1788299502057,"change":-0.01,"changeRate":-0.007519,"amplitude":0.007519},"delay":0,"changeRate":0,"floatShares":115999999,"shares":188000000,"eps":-1.223678,"marketStatus":"Post-Mkt","change":0,"latestTime":"09-01 18:30:08 EDT","open":1.33,"high":1.36,"low":1.31,"amount":709956.2480295,"amplitude":0.037594,"askPrice":1.43,"askSize":115,"bidPrice":1.28,"bidSize":2082,"shortable":3,"etf":0,"ttmEps":-1.223678,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1788307200000},"marketStatusCode":4,"adr":0,"listingDate":1694750400000,"exchange":"NASDAQ","adjPreClose":1.33,"preHourTrading":{"tag":"盘前","latestPrice":1.34,"preClose":1.33,"latestTime":"09:28 EDT","volume":2645,"amount":3720.5897790000004,"timestamp":1788269285094,"change":0.01,"changeRate":0.007519,"amplitude":0.075188},"postHourTrading":{"tag":"盘后","latestPrice":1.32,"preClose":1.33,"latestTime":"17:51 EDT","volume":1585,"amount":2107.050182,"timestamp":1788299502057,"change":-0.01,"changeRate":-0.007519,"amplitude":0.007519},"volumeRatio":0.926229,"impliedVol":1.9146,"impliedVolPercentile":0.7222},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NMRA\",,,,,undefined,":{"symbol":"NMRA","floatShares":115999999,"roa":"-73.85%","roe":"-187.11%","lyrEps":-1.450067,"volumeRatio":0.926229,"shares":188000000,"dividePrice":0,"high":1.36,"amplitude":0.037594,"preClose":1.33,"low":1.31,"week52Low":0.83015,"pbRate":"5.62","week52High":3.65,"institutionHeld":0,"latestPrice":1.33,"committee":0.895312,"eps":-1.223678,"divideRate":0,"volume":532615,"delay":0,"ttmEps":-1.223678,"open":1.33,"prevYearClose":1.79,"prevWeekClose":1.39,"prevMonthClose":1.33,"prevQuarterClose":1.7,"fiveDayClose":1.5,"twentyDayClose":1.6,"sixtyDayClose":1.63},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NMRA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-14","symbol":"NMRA","fiscalQuarterEnding":"2026/06","expectedEps":-0.23,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1786680000000,"reportTimeType":"pre","actualEps":-0.23},{"market":"US","date":"2026-05-07","symbol":"NMRA","fiscalQuarterEnding":"2026/03","expectedEps":-0.32,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1778126400000,"reportTimeType":"pre","actualEps":-0.3},{"market":"US","date":"2026-03-30","symbol":"NMRA","fiscalQuarterEnding":"2025/12","expectedEps":-0.34,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1774843200000,"reportTimeType":"pre","actualEps":-0.35},{"market":"US","date":"2025-11-06","symbol":"NMRA","fiscalQuarterEnding":"2025/09","expectedEps":-0.34,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1762405200000,"reportTimeType":"pre","actualEps":-0.35},{"market":"US","date":"2025-08-06","symbol":"NMRA","fiscalQuarterEnding":"2025/06","expectedEps":-0.38,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1754452800000,"reportTimeType":"post","actualEps":-0.33}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NMRA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NMRA\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.4444,"hold":0.1111,"sell":0.1111,"strongSell":0,"meanLabel":"BUY","meanPercent":0.4444,"analysts":9,"updateTime":1771387200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/NMRA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"NMRA","date":"2026-08-31","current":-1.086887,"percent":0.730715,"low":-19.620035,"twenty":-8.540167,"median":-1.72379,"eighty":-1.072332,"high":-0.385538,"avg":-4.810521,"sd":4.918024,"marketCap":261175317},"quantilePoints":[{"date":"2023-09-15","current":-19.620035,"twenty":-19.620035,"median":-19.620035,"eighty":-19.620035,"marketCap":2583134632},{"date":"2023-09-22","current":-12.753675,"twenty":-18.754446,"median":-15.453663,"eighty":-12.753675,"marketCap":1679123396},{"date":"2023-09-28","current":-13.691957,"twenty":-17.415667,"median":-13.628246,"eighty":-12.772209,"marketCap":1802655635},{"date":"2023-10-05","current":-13.813351,"twenty":-16.65135,"median":-13.723658,"eighty":-12.773914,"marketCap":1818638110},{"date":"2023-10-13","current":-11.180579,"twenty":-14.994038,"median":-13.691957,"eighty":-12.763183,"marketCap":1472012710},{"date":"2023-10-20","current":-11.493728,"twenty":-13.94093,"median":-13.080265,"eighty":-11.639864,"marketCap":1513241282},{"date":"2023-10-27","current":-14.254079,"twenty":-14.080107,"median":-13.080265,"eighty":-11.690896,"marketCap":1876663508},{"date":"2023-11-03","current":-10.734234,"twenty":-13.848145,"median":-12.776843,"eighty":-11.493728,"marketCap":1667466680},{"date":"2023-11-10","current":-10.420012,"twenty":-13.826354,"median":-12.7442,"eighty":-11.403032,"marketCap":1618655149},{"date":"2023-11-17","current":-11.79624,"twenty":-13.813351,"median":-12.154821,"eighty":-11.403032,"marketCap":1832439792},{"date":"2023-11-24","current":-11.717599,"twenty":-13.766958,"median":-11.806071,"eighty":-11.438475,"marketCap":1820223526},{"date":"2023-12-01","current":-12.041995,"twenty":-13.704638,"median":-11.815901,"eighty":-11.48267,"marketCap":1870615621},{"date":"2023-12-08","current":-12.26809,"twenty":-13.59002,"median":-11.825731,"eighty":-11.493283,"marketCap":1905737383},{"date":"2023-12-15","current":-14.381583,"twenty":-13.717318,"median":-11.894542,"eighty":-11.493728,"marketCap":2234049513},{"date":"2023-12-22","current":-13.75245,"twenty":-13.821153,"median":-12.041995,"eighty":-11.521564,"marketCap":2136319390},{"date":"2023-12-29","current":-16.848963,"twenty":-14.008036,"median":-12.137729,"eighty":-11.563317,"marketCap":2617334836},{"date":"2024-01-05","current":-16.111698,"twenty":-14.24211,"median":-12.26809,"eighty":-11.573312,"marketCap":2502807349},{"date":"2024-01-12","current":-14.991056,"twenty":-14.660761,"median":-12.728927,"eighty":-11.585874,"marketCap":2328725569},{"date":"2024-01-19","current":-14.411074,"twenty":-14.428768,"median":-12.751722,"eighty":-11.613398,"marketCap":2238630612},{"date":"2024-01-26","current":-14.843603,"twenty":-15.020547,"median":-12.776843,"eighty":-11.648787,"marketCap":2305820071},{"date":"2024-02-02","current":-14.991056,"twenty":-15.264335,"median":-13.370218,"eighty":-11.652719,"marketCap":2328725569},{"date":"2024-02-09","current":-17.1537,"twenty":-15.346909,"median":-13.691957,"eighty":-11.671529,"marketCap":2664672864},{"date":"2024-02-16","current":-18.490607,"twenty":-15.539581,"median":-13.783396,"eighty":-11.691031,"marketCap":2872349373},{"date":"2024-02-23","current":-18.500437,"twenty":-15.932789,"median":-13.819852,"eighty":-11.69454,"marketCap":2873876407},{"date":"2024-03-01","current":-17.330643,"twenty":-16.668088,"median":-13.939224,"eighty":-11.709735,"marketCap":2692159461},{"date":"2024-03-08","current":-12.297819,"twenty":-16.990518,"median":-13.97363,"eighty":-11.717599,"marketCap":2901363004},{"date":"2024-03-15","current":-10.189453,"twenty":-16.81554,"median":-13.826354,"eighty":-11.69454,"marketCap":2403946708},{"date":"2024-03-22","current":-9.414974,"twenty":-16.668088,"median":-13.783396,"eighty":-11.650753,"marketCap":2221227691},{"date":"2024-03-28","current":-8.492333,"twenty":-16.613039,"median":-13.722203,"eighty":-11.579976,"marketCap":2003553733},{"date":"2024-04-05","current":-9.246609,"twenty":-16.364935,"median":-13.534996,"eighty":-11.491504,"marketCap":2181506166},{"date":"2024-04-12","current":-9.435178,"twenty":-16.111698,"median":-12.865966,"eighty":-11.216259,"marketCap":2225994275},{"date":"2024-04-19","current":-7.105005,"twenty":-15.954415,"median":-12.753675,"eighty":-10.606446,"marketCap":1676248365},{"date":"2024-04-26","current":-6.123304,"twenty":-15.846283,"median":-12.728927,"eighty":-10.162515,"marketCap":1444640411},{"date":"2024-05-03","current":-6.231441,"twenty":-15.669339,"median":-12.297819,"eighty":-9.792112,"marketCap":1470152824},{"date":"2024-05-10","current":-6.135514,"twenty":-15.610358,"median":-12.155389,"eighty":-9.435178,"marketCap":1558549450},{"date":"2024-05-17","current":-6.047595,"twenty":-15.433415,"median":-12.120637,"eighty":-9.273547,"marketCap":1536216091},{"date":"2024-05-24","current":-5.846636,"twenty":-15.423584,"median":-11.91675,"eighty":-8.957021,"marketCap":1485168412},{"date":"2024-05-31","current":-6.085275,"twenty":-15.399992,"median":-11.884712,"eighty":-8.469435,"marketCap":1545787530},{"date":"2024-06-07","current":-6.235993,"twenty":-15.362637,"median":-11.806071,"eighty":-7.09423,"marketCap":1584073290},{"date":"2024-06-14","current":-6.248553,"twenty":-15.342977,"median":-11.75692,"eighty":-6.904314,"marketCap":1587263770},{"date":"2024-06-21","current":-5.557759,"twenty":-15.335113,"median":-11.717599,"eighty":-6.419582,"marketCap":1411787373},{"date":"2024-06-28","current":-5.777557,"twenty":-15.335113,"median":-11.707769,"eighty":-6.279953,"marketCap":1467620772},{"date":"2024-07-05","current":-6.129234,"twenty":-15.228947,"median":-11.690896,"eighty":-6.264891,"marketCap":1556954210},{"date":"2024-07-12","current":-7.253346,"twenty":-15.12278,"median":-11.653703,"eighty":-6.277441,"marketCap":1842502165},{"date":"2024-07-15","current":-6.939348,"twenty":-15.110984,"median":-11.648787,"eighty":-6.278697,"marketCap":1762740166},{"date":"2024-08-02","current":-7.931581,"twenty":-15.099188,"median":-11.648787,"eighty":-6.279953,"marketCap":2014788082},{"date":"2024-08-09","current":-6.56038,"twenty":-15.040207,"median":-11.579976,"eighty":-6.279953,"marketCap":1798711865},{"date":"2024-08-16","current":-6.881395,"twenty":-14.991056,"median":-11.493728,"eighty":-6.279953,"marketCap":1886727125},{"date":"2024-08-23","current":-6.712133,"twenty":-14.991056,"median":-11.447336,"eighty":-6.393648,"marketCap":1840319079},{"date":"2024-08-30","current":-6.54287,"twenty":-14.922244,"median":-11.299816,"eighty":-6.436952,"marketCap":1793911032},{"date":"2024-09-06","current":-6.297731,"twenty":-14.859331,"median":-10.957407,"eighty":-6.374465,"marketCap":1726699379},{"date":"2024-09-13","current":-6.904742,"twenty":-14.68632,"median":-10.606446,"eighty":-6.374465,"marketCap":1893128235},{"date":"2024-09-20","current":-7.430039,"twenty":-14.481851,"median":-10.304733,"eighty":-6.410301,"marketCap":2037153206},{"date":"2024-09-27","current":-7.634321,"twenty":-14.416972,"median":-9.973946,"eighty":-6.432454,"marketCap":2093162917},{"date":"2024-10-04","current":-7.905725,"twenty":-14.387481,"median":-9.835887,"eighty":-6.454177,"marketCap":2167575819},{"date":"2024-10-11","current":-8.988421,"twenty":-14.365855,"median":-9.536197,"eighty":-6.471402,"marketCap":2464427288},{"date":"2024-10-18","current":-9.898936,"twenty":-14.275648,"median":-9.492422,"eighty":-6.494727,"marketCap":2714070572},{"date":"2024-10-25","current":-7.587628,"twenty":-14.23812,"median":-9.435178,"eighty":-6.5109,"marketCap":2080360698},{"date":"2024-10-31","current":-7.126534,"twenty":-14.186945,"median":-9.414974,"eighty":-6.517189,"marketCap":1953938778},{"date":"2024-11-08","current":-7.599301,"twenty":-14.11026,"median":-9.329429,"eighty":-6.519524,"marketCap":2083561252},{"date":"2024-11-15","current":-6.430581,"twenty":-14.036864,"median":-9.246609,"eighty":-6.508113,"marketCap":1888648838},{"date":"2024-11-22","current":-5.330396,"twenty":-14.008036,"median":-9.078889,"eighty":-6.434404,"marketCap":1565526710},{"date":"2024-11-29","current":-5.467919,"twenty":-13.980511,"median":-8.972721,"eighty":-6.336098,"marketCap":1605916976},{"date":"2024-12-06","current":-5.313893,"twenty":-13.902792,"median":-8.614876,"eighty":-6.276185,"marketCap":1560679878},{"date":"2024-12-13","current":-5.819979,"twenty":-13.839429,"median":-8.495238,"eighty":-6.248553,"marketCap":1709316057},{"date":"2024-12-20","current":-5.775971,"twenty":-13.821153,"median":-8.377845,"eighty":-6.222869,"marketCap":1696391172},{"date":"2024-12-27","current":-6.238049,"twenty":-13.812967,"median":-8.200475,"eighty":-6.175381,"marketCap":1832102465},{"date":"2025-01-03","current":-1.083682,"twenty":-13.811432,"median":-8.147945,"eighty":-6.157876,"marketCap":318275296},{"date":"2025-01-10","current":-1.303719,"twenty":-13.766574,"median":-7.931581,"eighty":-6.140538,"marketCap":382899721},{"date":"2025-01-17","current":-1.193701,"twenty":-13.753032,"median":-7.891133,"eighty":-6.119668,"marketCap":350587508},{"date":"2025-01-24","current":-1.1882,"twenty":-13.716154,"median":-7.812392,"eighty":-6.085275,"marketCap":348971898},{"date":"2025-01-31","current":-1.056178,"twenty":-13.615504,"median":-7.634321,"eighty":-6.067691,"marketCap":310197242},{"date":"2025-02-07","current":-1.07268,"twenty":-13.546812,"median":-7.564281,"eighty":-5.978405,"marketCap":315044074},{"date":"2025-02-14","current":-0.929656,"twenty":-13.337262,"median":-7.53602,"eighty":-5.966304,"marketCap":273038198},{"date":"2025-02-21","current":-0.940658,"twenty":-13.1053,"median":-7.470895,"eighty":-5.920328,"marketCap":276269419},{"date":"2025-02-28","current":-0.852643,"twenty":-12.883791,"median":-7.424202,"eighty":-5.847483,"marketCap":250419649},{"date":"2025-03-07","current":-1.009931,"twenty":-12.773914,"median":-7.253346,"eighty":-5.800175,"marketCap":246207962},{"date":"2025-03-14","current":-0.930199,"twenty":-12.763183,"median":-7.144044,"eighty":-5.763741,"marketCap":226770492},{"date":"2025-03-21","current":-0.770737,"twenty":-12.752113,"median":-7.105005,"eighty":-5.687956,"marketCap":187895550},{"date":"2025-03-28","current":-0.730871,"twenty":-12.743752,"median":-7.036301,"eighty":-5.574632,"marketCap":178176815},{"date":"2025-04-04","current":-0.564099,"twenty":-12.730087,"median":-6.998128,"eighty":-5.417311,"marketCap":137520105},{"date":"2025-04-11","current":-0.476129,"twenty":-12.580434,"median":-6.945391,"eighty":-5.374404,"marketCap":116074096},{"date":"2025-04-17","current":-0.41859,"twenty":-12.352677,"median":-6.926527,"eighty":-5.321594,"marketCap":102046721},{"date":"2025-04-25","current":-0.497989,"twenty":-12.291873,"median":-6.904742,"eighty":-1.375231,"marketCap":121403202},{"date":"2025-05-02","current":-0.511809,"twenty":-12.245663,"median":-6.881395,"eighty":-1.223405,"marketCap":124772347},{"date":"2025-05-09","current":-0.423699,"twenty":-12.15573,"median":-6.846375,"eighty":-1.1893,"marketCap":103292222},{"date":"2025-05-16","current":-0.417316,"twenty":-12.148314,"median":-6.834702,"eighty":-1.12879,"marketCap":107691766},{"date":"2025-05-23","current":-0.449909,"twenty":-12.121955,"median":-6.75723,"eighty":-1.07488,"marketCap":116102658},{"date":"2025-05-30","current":-0.450473,"twenty":-12.120637,"median":-6.747152,"eighty":-1.061679,"marketCap":116248231},{"date":"2025-06-06","current":-0.507762,"twenty":-12.041995,"median":-6.685868,"eighty":-1.033834,"marketCap":131031991},{"date":"2025-06-13","current":-0.562731,"twenty":-11.924033,"median":-6.5954,"eighty":-0.989998,"marketCap":145217284},{"date":"2025-06-20","current":-0.488895,"twenty":-11.91238,"median":-6.57789,"eighty":-0.951354,"marketCap":126163379},{"date":"2025-06-27","current":-0.501055,"twenty":-11.897527,"median":-6.552046,"eighty":-0.939895,"marketCap":129301288},{"date":"2025-07-03","current":-0.51497,"twenty":-11.882746,"median":-6.531197,"eighty":-0.932192,"marketCap":132892092},{"date":"2025-07-11","current":-0.664396,"twenty":-11.845391,"median":-6.513687,"eighty":-0.915408,"marketCap":171452797},{"date":"2025-07-18","current":-1.071809,"twenty":-11.813935,"median":-6.466558,"eighty":-0.901766,"marketCap":276588946},{"date":"2025-07-25","current":-1.435347,"twenty":-11.800172,"median":-6.430581,"eighty":-0.91143,"marketCap":370402741},{"date":"2025-08-01","current":-1.228506,"twenty":-11.772648,"median":-6.345689,"eighty":-0.913154,"marketCap":317025927},{"date":"2025-08-08","current":-1.05869,"twenty":-11.733327,"median":-6.279953,"eighty":-0.915408,"marketCap":266884071},{"date":"2025-08-15","current":-1.015014,"twenty":-11.717599,"median":-6.27111,"eighty":-0.917957,"marketCap":255873774},{"date":"2025-08-22","current":-1.053558,"twenty":-11.711701,"median":-6.248553,"eighty":-0.922507,"marketCap":265590500},{"date":"2025-08-29","current":-1.130648,"twenty":-11.697847,"median":-6.240161,"eighty":-0.927824,"marketCap":285023951},{"date":"2025-09-05","current":-1.047134,"twenty":-11.691098,"median":-6.234271,"eighty":-0.929873,"marketCap":263971046},{"date":"2025-09-12","current":-1.066407,"twenty":-11.688352,"median":-6.217154,"eighty":-0.931528,"marketCap":268829408},{"date":"2025-09-19","current":-1.00859,"twenty":-11.674168,"median":-6.167847,"eighty":-0.932308,"marketCap":254254320},{"date":"2025-09-26","current":-1.092103,"twenty":-11.654686,"median":-6.150338,"eighty":-0.934175,"marketCap":275307225},{"date":"2025-10-03","current":-1.143496,"twenty":-11.648787,"median":-6.138654,"eighty":-0.935832,"marketCap":288262860},{"date":"2025-10-10","current":-1.252707,"twenty":-11.625195,"median":-6.129234,"eighty":-0.937276,"marketCap":315793582},{"date":"2025-10-17","current":-1.143496,"twenty":-11.585874,"median":-6.098338,"eighty":-0.939018,"marketCap":288262860},{"date":"2025-10-24","current":-1.483976,"twenty":-11.573312,"median":-6.085275,"eighty":-0.940658,"marketCap":374093936},{"date":"2025-10-31","current":-1.882272,"twenty":-11.535481,"median":-6.072715,"eighty":-0.944448,"marketCap":474500101},{"date":"2025-11-07","current":-1.768195,"twenty":-11.493728,"median":-6.047595,"eighty":-0.950132,"marketCap":417819201},{"date":"2025-11-14","current":-1.902139,"twenty":-11.492838,"median":-5.97813,"eighty":-0.950743,"marketCap":449469716},{"date":"2025-11-21","current":-1.668791,"twenty":-11.473837,"median":-5.972235,"eighty":-0.95386,"marketCap":394330309},{"date":"2025-11-28","current":-1.583937,"twenty":-11.438475,"median":-5.963003,"eighty":-0.958453,"marketCap":374279615},{"date":"2025-12-05","current":-1.608686,"twenty":-11.3991,"median":-5.921482,"eighty":-0.963621,"marketCap":380127734},{"date":"2025-12-12","current":-1.488688,"twenty":-11.349949,"median":-5.869128,"eighty":-0.966191,"marketCap":351772572},{"date":"2025-12-19","current":-1.236978,"twenty":-11.209123,"median":-5.84706,"eighty":-0.976733,"marketCap":292294118},{"date":"2025-12-26","current":-1.301703,"twenty":-11.180579,"median":-5.82548,"eighty":-0.977791,"marketCap":307588578},{"date":"2026-01-02","current":-1.28732,"twenty":-10.823503,"median":-5.782265,"eighty":-0.97889,"marketCap":304189809},{"date":"2026-01-09","current":-1.675673,"twenty":-10.734234,"median":-5.771277,"eighty":-0.987831,"marketCap":395956567},{"date":"2026-01-16","current":-1.531839,"twenty":-10.632004,"median":-5.730809,"eighty":-0.990132,"marketCap":361968879},{"date":"2026-01-23","current":-1.510263,"twenty":-10.51228,"median":-5.690707,"eighty":-0.994023,"marketCap":356870726},{"date":"2026-01-30","current":-1.474305,"twenty":-10.431808,"median":-5.626838,"eighty":-0.999937,"marketCap":348373804},{"date":"2026-02-06","current":-1.409579,"twenty":-10.281677,"median":-5.512839,"eighty":-1.00602,"marketCap":333079344},{"date":"2026-02-13","current":-2.337313,"twenty":-10.17329,"median":-5.423912,"eighty":-1.009395,"marketCap":552299933},{"date":"2026-02-20","current":-2.502722,"twenty":-10.087087,"median":-5.390906,"eighty":-1.011964,"marketCap":591385774},{"date":"2026-02-27","current":-2.553064,"twenty":-9.944314,"median":-5.374404,"eighty":-1.018277,"marketCap":603281465},{"date":"2026-03-06","current":-2.157519,"twenty":-9.899493,"median":-5.330396,"eighty":-1.027437,"marketCap":509815323},{"date":"2026-03-13","current":-2.258203,"twenty":-9.891226,"median":-5.316643,"eighty":-1.03397,"marketCap":533606704},{"date":"2026-03-20","current":-1.848275,"twenty":-9.844641,"median":-2.553064,"eighty":-1.034185,"marketCap":436741793},{"date":"2026-03-27","current":-1.790741,"twenty":-9.769472,"median":-2.506318,"eighty":-1.034236,"marketCap":423146718},{"date":"2026-04-02","current":-1.605828,"twenty":-9.718546,"median":-2.484743,"eighty":-1.034286,"marketCap":380465575},{"date":"2026-04-10","current":-1.598144,"twenty":-9.645471,"median":-2.437997,"eighty":-1.035523,"marketCap":378645165},{"date":"2026-04-17","current":-1.536677,"twenty":-9.606931,"median":-2.340909,"eighty":-1.040518,"marketCap":364081890},{"date":"2026-04-24","current":-1.719486,"twenty":-9.518687,"median":-2.301354,"eighty":-1.04071,"marketCap":407394409},{"date":"2026-05-01","current":-1.904543,"twenty":-9.445953,"median":-2.229437,"eighty":-1.041995,"marketCap":451239547},{"date":"2026-05-08","current":-1.495876,"twenty":-9.432484,"median":-2.171903,"eighty":-1.047134,"marketCap":354414867},{"date":"2026-05-15","current":-1.618279,"twenty":-9.420361,"median":-2.157519,"eighty":-1.047134,"marketCap":359895509},{"date":"2026-05-22","current":-1.519703,"twenty":-9.409586,"median":-2.064027,"eighty":-1.047134,"marketCap":337972940},{"date":"2026-05-29","current":-1.544347,"twenty":-9.388035,"median":-2.022348,"eighty":-1.047134,"marketCap":343453582},{"date":"2026-06-05","current":-1.437557,"twenty":-9.385312,"median":-1.929745,"eighty":-1.050677,"marketCap":319704133},{"date":"2026-06-12","current":-1.48298,"twenty":-9.273547,"median":-1.902139,"eighty":-1.053558,"marketCap":329805954},{"date":"2026-06-18","current":-1.274697,"twenty":-9.262772,"median":-1.884704,"eighty":-1.052982,"marketCap":283484893},{"date":"2026-06-26","current":-1.258034,"twenty":-9.249303,"median":-1.881168,"eighty":-1.053558,"marketCap":279779208},{"date":"2026-07-02","current":-1.349679,"twenty":-9.177916,"median":-1.861064,"eighty":-1.05513,"marketCap":300160475},{"date":"2026-07-10","current":-1.374673,"twenty":-9.115941,"median":-1.805124,"eighty":-1.057685,"marketCap":305719002},{"date":"2026-07-17","current":-1.333016,"twenty":-9.073636,"median":-1.796333,"eighty":-1.060483,"marketCap":296454790},{"date":"2026-07-24","current":-1.299691,"twenty":-9.014102,"median":-1.790741,"eighty":-1.061679,"marketCap":289043420},{"date":"2026-07-31","current":-1.374673,"twenty":-8.975861,"median":-1.781172,"eighty":-1.06357,"marketCap":305719002},{"date":"2026-08-07","current":-1.366342,"twenty":-8.932776,"median":-1.776358,"eighty":-1.066407,"marketCap":303866160},{"date":"2026-08-14","current":-1.441324,"twenty":-8.783796,"median":-1.768195,"eighty":-1.066716,"marketCap":320541742},{"date":"2026-08-21","current":-1.338045,"twenty":-8.610207,"median":-1.734908,"eighty":-1.069031,"marketCap":284662306},{"date":"2026-08-28","current":-1.307133,"twenty":-8.561179,"median":-1.728093,"eighty":-1.072157,"marketCap":278085949},{"date":"2026-08-31","current":-1.227645,"twenty":-8.540167,"median":-1.72379,"eighty":-1.072332,"marketCap":261175317}],"updateTime":1788301808192},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NMRA\",pageSize:20,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2623882325","title":"Neumora Therapeutics Price Target Maintained With a $8.00/Share by Needham","url":"https://stock-news.laohu8.com/highlight/detail?id=2623882325","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623882325?lang=en_us&edition=fundamental","pubTime":"2026-03-31 18:43","pubTimestamp":1774953780,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/NMRA/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 31, 2026 06:43 ET (10:43 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NMRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623030843","title":"Neumora Therapeutics Warns Nasdaq Delisting Risk Could Hit Liquidity, Share Price, and Capital Access","url":"https://stock-news.laohu8.com/highlight/detail?id=2623030843","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623030843?lang=en_us&edition=fundamental","pubTime":"2026-03-31 14:01","pubTimestamp":1774936868,"startTime":"0","endTime":"0","summary":"Neumora Therapeutics, Inc. (NMRA) has disclosed a new risk, in the Share Price & Shareholder Rights category. Neumora Therapeutics, Inc. faces a ma...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/neumora-therapeutics-warns-nasdaq-delisting-risk-could-hit-liquidity-share-price-and-capital-access?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/neumora-therapeutics-warns-nasdaq-delisting-risk-could-hit-liquidity-share-price-and-capital-access?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NQmain","NMRA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623456183","title":"Analysts Conflicted on These Healthcare Names: Connect Biopharma Holdings (CNTB), Neumora Therapeutics, Inc. (NMRA) and Merck & Company (MRK)","url":"https://stock-news.laohu8.com/highlight/detail?id=2623456183","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623456183?lang=en_us&edition=fundamental","pubTime":"2026-03-30 21:40","pubTimestamp":1774878027,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Connect Biopharma Holdings (CNTB), Neumora Therape...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-connect-biopharma-holdings-cntb-neumora-therapeutics-inc-nmra-and-merck-company-mrk-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-connect-biopharma-holdings-cntb-neumora-therapeutics-inc-nmra-and-merck-company-mrk-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1116320737.USD","LU2112291526.USD","NMRA","LU1093756168.USD","BK4007","IE000M9KFDE8.USD","LU2106854487.HKD","LU0965509010.AUD","BK4516","BK4137","LU1069347547.HKD","LU0130102774.USD","LU1934455277.USD","LU1941712264.USD","BK4534","LU1057294990.SGD","LU0648001328.SGD","LU1430594728.SGD","LU0985320562.USD","XBI","LU0070302665.USD","IE00BN8TJ469.HKD","LU2023250843.SGD","LU1941712348.USD","LU2324357040.USD","LABU","LU1066051811.HKD","LU1571399168.USD","LU0868494617.USD","LU1934455863.HKD","SG9999014567.USD","LU2125154935.USD","SG9999002224.SGD","LU2361045086.USD","LU0058720904.USD","LU1291159041.SGD","LU2461242641.AUD","LU1989772923.USD","LU1066053197.SGD","BK4588","IE00BBT3K403.USD","LU1934455194.USD","SG9999014575.USD","BK4139","LU2360032135.SGD","IE00BSNM7G36.USD","IE00BJJMRZ35.SGD","LU1989771016.USD","LU1061106388.HKD","LU1929549753.HKD","SG9999014542.SGD","BK4585","LU0203345920.USD","LU0965508806.USD","LU0965509101.SGD","IE00BLSP4239.USD","SGXZ57979304.SGD","LU0861579265.USD","IE00BFTCPJ56.SGD","LU0868494708.USD","MRK","SG9999015358.SGD","LU0211331839.USD","LU0006306889.USD","LU1035773651.USD","SG9999001176.USD","IE00BJT1NW94.SGD","BK4550","LU1917777945.USD","LU0029874061.USD","LU0477156953.USD","LU0265550946.USD","LU0320765489.SGD","LU0320765646.SGD","LU1093756325.SGD","BK4581","IE00B2B36J28.USD","SG9999014559.SGD","LU0106261372.USD","LU0128526141.USD","LU0965509283.SGD","LU1201861249.SGD","IE0009355771.USD","SG9999001440.SGD","LU1983299246.USD","LU0980610538.SGD","LU0098860793.USD","LU0208291251.USD","SG9999001176.SGD","LU0432979614.USD","LU1116320901.HKD","LU0130517989.USD","LU1974910355.USD","IE00B4R5TH58.HKD","LU1066051225.USD","LU0203347892.USD","IE0002141913.USD","LU2468319806.SGD","LU2089984988.USD","LU0266013472.USD","IE00B1BXHZ80.USD","LU0122379950.USD","LU2361044865.SGD","LU0238689110.USD","LU1037948541.HKD","SG9999015341.SGD","LU1037948897.HKD","LU0234572021.USD","LU2125154778.USD","LU0265550359.USD","BK4559","SG9999013999.USD","BK4533","LU0942090050.USD","LU1699723380.USD","IE00BLSP4452.SGD","LU2361044949.HKD","CNTB","LU1585245621.USD","LU1023059063.AUD","LU2023250504.SGD","LU1989772840.SGD","LU0289739699.SGD","LU1162221912.USD","SG9999002232.USD","LU1066051498.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623343178","title":"Neumora Therapeutics Inc reports results for the quarter ended December 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2623343178","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623343178?lang=en_us&edition=fundamental","pubTime":"2026-03-30 21:25","pubTimestamp":1774877111,"startTime":"0","endTime":"0","summary":"Neumora Therapeutics Inc reports results for the quarter ended December 31 - Earnings SummaryNeumora Therapeutics Inc NMRA.OQ reported a quarterly adjusted loss of 35 cents per share for the quarter e","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260330:nL8N40I13Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NMRA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623314373","title":"Neumora Therapeutics Q4 EPS $(0.35) Misses $(0.33) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2623314373","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623314373?lang=en_us&edition=fundamental","pubTime":"2026-03-30 19:21","pubTimestamp":1774869716,"startTime":"0","endTime":"0","summary":"Neumora Therapeutics (NASDAQ:NMRA) reported quarterly losses of $(0.35) per share which missed the analyst consensus estimate of $(0.33) by 7.36 percent. This is a 5.41 percent increase over losses of $(0.37) per share","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/03/51534728/neumora-therapeutics-q4-eps-0-35-misses-0-33-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NMRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623311507","title":"Neumora Therapeutics reports Q4 EPS (35c), consensus (33c)","url":"https://stock-news.laohu8.com/highlight/detail?id=2623311507","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623311507?lang=en_us&edition=fundamental","pubTime":"2026-03-30 19:00","pubTimestamp":1774868407,"startTime":"0","endTime":"0","summary":"“We saw significant progress in 2025, laying the foundation for a catalyst-rich year ahead as we advance our pipeline of next-generation therapies ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/neumora-therapeutics-reports-q4-eps-35c-consensus-33c-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/neumora-therapeutics-reports-q4-eps-35c-consensus-33c-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NMRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623319749","title":"Neumora FY25 net loss narrows to $237 million; cash drops to $183 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2623319749","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623319749?lang=en_us&edition=fundamental","pubTime":"2026-03-30 18:53","pubTimestamp":1774868025,"startTime":"0","endTime":"0","summary":"Neumora posted a Q4 net loss of USD 59 million, with loss per share at USD 0.35.Full-year net loss narrowed to USD 237 million, with loss per share improving to USD 1.45.Operating loss widened to USD 241 million as R&D spend eased to USD 176 million.Cash, cash equivalents and marketable securities fell to USD 183 million.Pipeline update: KOASTAL-2 and KOASTAL-3 were fully enrolled in Q1 2026, with a joint topline readout expected in Q2 2026.Management highlighted “catalyst-rich” 2026, citing new Phase 1b data supporting NMRA-511’s profile in Alzheimer’s disease agitation.Outlook: cash on hand is expected to fund operations into Q3 2027.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260330:nNDLb94WQ8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NMRA","IE00B64PRP62.GBP","NDAQ","BK4588","LU0314104364.USD","SG9999014005.SGD","IE00BN0W2W23.USD","IE00BKPKM429.USD","IE00BN0W2V16.EUR","IE00BGHQF748.EUR","IE00B3QW5Z07.USD","LU2210149790.SGD","LU2210150020.SGD","IE00BN0W2T93.GBP","SG9999014039.USD","LU2095319765.USD","BK4007","SG9999014013.SGD","BK4112","BK4585","SG9999014021.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623319073","title":"Neumora Therapeutics Inc: NOW Expects to Bring Nmra-215 Into Clinic in Q1 of 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2623319073","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623319073?lang=en_us&edition=fundamental","pubTime":"2026-03-30 18:53","pubTimestamp":1774868007,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260330:nTUA1THWRH:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","NMRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623731901","title":"Press Release: Neumora Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2623731901","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623731901?lang=en_us&edition=fundamental","pubTime":"2026-03-30 18:53","pubTimestamp":1774867980,"startTime":"0","endTime":"0","summary":"New data for NMRA-511 supports unsurpassed clinical effect in a pre-specified population comparable to Rexulti and Auvelity pivotal studies. KOASTAL-2 and -3 fully enrolled in the first quarter of 2026; on track for topline readout in the second quarter of 2026. NMRA-898 selected as lead program in M4 franchise based on promising clinical results from ongoing Phase 1 study. \"We saw significant progress in 2025, laying the foundation for a catalyst-rich year ahead as we advance our pipeline of next-generation therapies for people living with brain diseases,\" said Paul L. Berns, co-founder, chairman and chief executive officer of Neumora. \"In the first quarter of 2026, we confirmed next steps for navacaprant and our M4 franchise, as well as generated compelling results supporting the potential unsurpassed profile of NMRA-511 in Alzheimer's disease agitation, which we built upon today with the announcement of additional data from a pre-specified analysis.\"","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PAM","NMRA","BK4132","BK4563","BK4081","BK4007","AD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623193063","title":"Neumora publishes corporate presentation outlining neuroscience pipeline and upcoming clinical milestones","url":"https://stock-news.laohu8.com/highlight/detail?id=2623193063","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623193063?lang=en_us&edition=fundamental","pubTime":"2026-03-30 18:35","pubTimestamp":1774866959,"startTime":"0","endTime":"0","summary":"Neumora outlined late-stage plan for navacaprant in major depressive disorder, with KOASTAL-2 and KOASTAL-3 topline data targeted for 1Q 2027.Pipeline update highlighted NMRA-511 for agitation in Alzheimer’s disease, with extension data expected in 2Q 2026.Company targets initiation of NMRA-511 Phase 2 study in 2H 2026.Metabolic franchise timeline calls for start of NMRA-215 clinical program for obesity in 1Q 2027.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Neumora Therapeutics Inc published the original content used to generate this news brief on March 30, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260330:nNDL76nHwK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NMRA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623315199","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2623315199","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623315199?lang=en_us&edition=fundamental","pubTime":"2026-03-30 18:00","pubTimestamp":1774864800,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.·INmune Bio Inc.                                 4Q      (.26)  4:05 PM. ·Dave & Buster                                   4Q       .39   4:05 PM. ·NIKE Class B                                     3Q       .29   4:15 PM","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IMNN","BTBT","MKC.V","BEEM","MSM","AEHR","BITF","FC","PVLA","BNZI","PHR","AIRO","JILL","APOG","KEEL","PRGS","PLAY","BCAX","NCNO","AIRJ","NNOX","BIRD","AYI","CALM","CAG","NEOG","NGEN","RNXT","PROP","CRDL","BYND","MAZE","AURA","PENG","FDS","BHST","PRPL","ANGO","SGML","MKC","SGMO","DMAC","INMB","INV","NKE","NMRA","RH","LNN","LW","NKLR","PVH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622241824","title":"Neumora Therapeutics Inc  expected to post a loss of 33 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2622241824","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622241824?lang=en_us&edition=fundamental","pubTime":"2026-03-27 21:13","pubTimestamp":1774617185,"startTime":"0","endTime":"0","summary":"Neumora Therapeutics Inc  expected to post a loss of33cents a share - Earnings Preview Neumora Therapeutics Inc NMRA.OQ NMRA.O is expected to  show no change in quarterly revenue when it reports  resu","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260327:nL8N40F14E:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","NMRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622847966","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2622847966","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622847966?lang=en_us&edition=fundamental","pubTime":"2026-03-27 18:00","pubTimestamp":1774605600,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.·SBC Med Grp Hld                                  4Q       .12       BMO. ·INmune Bio Inc                                  4Q      (.26)  4:05 PM. ·Banzai Intl Cl A                                4Q      (.59)      AMC. ·FactSet Res Sys                                  2Q      4.38   6:00 AM. ·McCormick & Co                                 1Q       .60   6:30 AM","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ANGO","KOPN","NKLR","BEEM","BHST","CRDL","AIRO","NEOG","CCL","AUTL","AYI","INMB","APOG","LNN","CALM","NKE","CAG","AEHR","HUMA","NMRA","BTBT","KYTX","MSLE","JILL","DMAC","PHR","PENG","RNXT","BYND","MKC.V","PRGS","DEFT","BIRD","IMNN","BCAX","LW","ATOS","BITF","FC","LGN","AIRJ","FDS","PLAY","NCNO","MSM","KEEL","AURA","NGEN","BNZI","INV","MKC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619452958","title":"Neumora Therapeutics to report Q4 and full-year 2025 financial results in conference call and webcast","url":"https://stock-news.laohu8.com/highlight/detail?id=2619452958","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619452958?lang=en_us&edition=fundamental","pubTime":"2026-03-16 19:00","pubTimestamp":1773658812,"startTime":"0","endTime":"0","summary":"Neumora will report fourth-quarter and full-year 2025 financial results on March 30, 2026. The company will host a conference call and live webcast at 8:00 a.m. ET on March 30, 2026. The webcast will be available at neumoratx.com.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260316:nNDL6fHRnN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQF748.EUR","BK4585","NDAQ","IE00BN0W2W23.USD","SG9999014005.SGD","IE00BKPKM429.USD","IE00BN0W2T93.GBP","NMRA","LU2210150020.SGD","LU0314104364.USD","SG9999014039.USD","SG9999014013.SGD","BK4007","BK4112","LU2210149790.SGD","BK4588","IE00B3QW5Z07.USD","SG9999014021.USD","IE00BN0W2V16.EUR","IE00B64PRP62.GBP","LU2095319765.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618362582","title":"LB Pharmaceuticals appoints Robert Lenz to board","url":"https://stock-news.laohu8.com/highlight/detail?id=2618362582","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618362582?lang=en_us&edition=fundamental","pubTime":"2026-03-09 20:01","pubTimestamp":1773057701,"startTime":"0","endTime":"0","summary":"LB Pharmaceuticals appointed Robert Lenz, M.D., Ph.D. to its board of directors. Lenz most recently served as executive vice president and head of R&D at Neumora Therapeutics.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260309:nNDL5Nc1ry:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2095319765.USD","SG9999014005.SGD","SG9999014013.SGD","LU2210149790.SGD","BK4112","LU2210150020.SGD","IE00B64PRP62.GBP","BK4007","NDAQ","IE00BGHQF748.EUR","BK4588","LU0314104364.USD","BK4585","LBRX","IE00BKPKM429.USD","SG9999014021.USD","NMRA","SG9999014039.USD","IE00B3QW5Z07.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":5,"totalSize":95,"code":"91000000","status":"200"}]}}